Skip to content

CELLYAN BIOTECHNOLOGY CO., LTD

HKPD

CIK 0002007702

← back to feed
Revenue (TTM)
$20.31M
+21.7% YoY Q2 Sep 2025
Net Income (TTM)
−$27.06K
−102.0% YoY Q2 Sep 2025
EPS Diluted (TTM)
−$0.00
−101.7% YoY Q2 Sep 2025
Gross Margin
11.9%
Q2 Sep 2025
Operating Margin
-11.2%
Q2 Sep 2025
Net Margin
-0.1%
Q2 Sep 2025
Free Cash Flow (TTM)
—
Q2 Sep 2025
Cash
$190.91K
Q2 Sep 2025
Total Debt
—
Q2 Sep 2025
Shares Outstanding
11M sh
Q2 Sep 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings